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chronic total occlusions (CTOs).
OBJECTIVES The authors describe the European experience with and outcomes of retrograde PCI revascularization for
coronary CTOs.
METHODS Follow-up data were collected from 1,395 patients with 1,582 CTO lesions enrolled between January 2008
and December 2012 for retrograde CTO PCI at 44 European centers. Major adverse cardiac and cerebrovascular events
were deﬁned as the composite of cardiac death, myocardial infarction, stroke, and further revascularization.
RESULTS The mean patient age was 62.0  10.4 years; 88.5% were men. Procedural and clinical success rates were
75.3% and 71.2%, respectively. The mean clinical follow-up duration was 24.7  15.0 months. Compared with patients
with failed retrograde PCI, successfully revascularized patients showed lower rates of cardiac death (0.6% vs. 4.3%,
respectively; p < 0.001), myocardial infarction (2.3% vs. 5.4%, respectively; p ¼ 0.001), further revascularization (8.6%
vs. 23.6%, respectively; p < 0.001), and major adverse cardiac and cerebrovascular events (8.7% vs. 23.9%, respec-
tively; p < 0.001). Female sex (hazard ratio [HR]: 2.06; 95% conﬁdence interval [CI]: 1.33 to 3.18; p ¼ 0.001), prior
PCI (HR: 1.73; 95% CI: 1.16 to 2.60; p ¼ 0.011), low left ventricular ejection fraction (HR: 2.43; 95% CI: 1.22 to 4.83;
p ¼ 0.011), J-CTO (Multicenter CTO Registry in Japan) score $3 (HR: 2.08; 95% CI: 1.32 to 3.27; p ¼ 0.002), and
procedural failure (HR: 2.48; 95% CI: 1.72 to 3.57; p < 0.001) were independent predictors of major adverse cardiac
and cerebrovascular events at long-term follow-up.
CONCLUSIONS The number of retrograde procedures in Europe has increased, with high percents of success, low rates
of major complications, and good long-term outcomes. (J Am Coll Cardiol 2015;65:2388–400) © 2015 by the American
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AND ACRONYM S
CABG = coronary artery bypass
grafting
CART = controlled antegrade
retrograde tracking
CI = conﬁdence interval
CTO = chronic total occlusion
HR = hazard ratio
MACCE = major adverse
cardiac and cerebrovascular
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2389S ince the ﬁrst report in 1990 (1), coronary chronictotal occlusion (CTO) recanalization throughretrograde collateral vessels remains a technical
challenge in interventional cardiology, greatly im-
proving success rates in complex CTO lesions not
amenable to antegrade techniques. Over the past 5
years, different retrograde techniques have been intro-
duced, as well as new guidewires, microcatheters, and
balloons dedicated to this approach (2–6). Japan,
Europe, and theUnited States have published initial re-
sults (7–12), followed by larger patients cohorts (13–16).SEE PAGE 2401
event(s)
MI = myocardial infarction
PCI = percutaneous coronary
intervention
TIMI = Thrombolysis In
Myocardial InfarctionThe aim of the present study was to describe
practice, procedural outcome, in-hospital events, and
long-term clinical follow-up after retrograde CTO
percutaneous coronary intervention (PCI) performed
by a large group of dedicated interventionalists who
are members of the Euro CTO Club.
METHODS
STUDY POPULATION. The European Registry of CTOs
(ERCTO) is a prospective real-world registry that in-
cludes patients treated via the retrograde or antero-
grade approach for 1 or more CTO lesions involving
major genuine coronary arteries (>2.5 mm) or
saphenous bypass conduits. Data collection was car-
ried out at 44 centers across Europe. All patients
undergoing retrograde or antegrade CTO PCI at these
centers between January 2008 and December 2012
were registered prospectively. There were no exclu-
sion criteria. Retrograde CTO PCIs were included as
ﬁrst-attempt procedures or as procedures after prior
failed antegrade attempts in the same or other ses-
sions. The treatment indication was symptomatic
myocardial ischemia and/or evidence of reversible
myocardial ischemia by perfusion imaging or stress
testing. Patient follow-up was performed either
by a clinical visit or by a telephone interview.
At follow-up, details regarding major adverseInfermi Hospital, Rivoli, Italy; ##Division of Cardiology, Zentralklinik Bad B
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Manuscript received January 7, 2015; revised manuscript received March 20cardiac and cerebrovascular event (MACCE)
occurrence, rehospitalization for cardiovas-
cular reasons, and symptoms were collected
by physicians through the revision of clinical
source documentation. The study was per-
formed in accordance with the Declaration of
Helsinki.
DEFINITIONS AND STUDY OUTCOMES. Coronary
CTOs were deﬁned as angiographic evidence
of total occlusions with TIMI (Thrombolysis
In Myocardial Infarction) ﬂow grade 0 and
estimated durations of at least 3 months.
Occlusion duration was divided into 3 levels
of certainty, as suggested by the EuroCTO
Club consensus document (17). Patients were
considered to have undergone retrograde
CTO PCI if a guidewire was introduced into a
collateral channel that supplied the target vessel
distal to the lesion (9). A procedure was deﬁned as an
antegrade CTO PCI if no guidewire was introduced
into a collateral channel, as previously deﬁned. Pro-
cedural success was deﬁned as angiographic success
(ﬁnal residual stenosis <20% by visual estimation and
TIMI ﬂow grade 3 after CTO recanalization). Clinical
success was deﬁned as a procedural success without
periprocedural complications. In-hospital MACCEs
were deﬁned as the composite of non-Q-wave and Q-
wave myocardial infarction (MI), recurrent angina
requiring urgent repeat revascularization with PCI or
coronary bypass surgery, stroke, and death. Non-Q-
wave MI was deﬁned as creatine kinase-MB enzyme
elevation >3 times the upper limit of normal. When
new pathological Q waves, in addition to enzyme
elevation, were observed on the electrocardiogram,
the event was deﬁned as a Q-wave MI. In all patients,
creatine kinase and creatine kinase-MB were evalu-
ated 6 h after the procedure and until their
normalization if levels were abnormal (18,19). The
complexity of CTO lesion was assessed through J-CTO
(Multicenter CTO Registry in Japan) score (0 ¼ easy,erka, Bad Berka, Germany; ***Department of Inter-
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FIGURE 1 Flowchart of the Study Population
ERCTO 
2008-2012
8,647 patients
9,643 lesions
Included
Antegrade Retrograde
Retrograde
(primary strategy)
Retrograde
(bail-out strategy)
202 patients
187 lesions (23.8%)
1,193 patients
1,205 lesions (76.2%)
1,395 patients
1,582 lesions
7,205 patients
8,007 lesions
Drop Out for Missing Data
47 patients
54 lesions
8,600 patients
9,589 lesions
Patients included in the multicenter European Registry of CTOs (ERCTO) Registry from 2008 to 2012.
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23901 ¼ intermediate, 2 ¼ difﬁcult, $3 ¼ very difﬁcult)
(20). At follow-up, MACCEs were deﬁned as the
composite of cardiac death, MI, stroke, and further
need for revascularization. Dyspnea and angina were
assessed according to New York Heart Association
and Canadian Cardiovascular Society classiﬁcations,
respectively, before the indexed procedure and dur-
ing follow-up.
INTERVENTIONAL PROCEDURES. All patients received
optimal intravenous hydration the days before and
after PCI. Patients received an initial bolus of
intravenous unfractioned heparin (100 IU/kg). The
activated clotting time was monitored every 30 min
to determine if an additional bolus of unfractioned
heparin was necessary to maintain an activated
clotting time >250 s. Upstream use of glyco-
protein IIb/IIIa inhibitor therapy or bivalirudin was
avoided.
Choice of CTO revascularization strategy was left
to the operator’s discretion. All procedures were
performed via the femoral route, with double coro-
nary cannulation and contralateral selective injec-
tion. Seven-French guiding catheters were used inmost cases. Several guidewire strategies were used,
including the single-wire technique, the parallel-wires
technique, the intravascular ultrasound–guided wir-
ing technique, and retrograde wiring through collat-
eral vessels, such as simple retrograde wiring, kissing
wires, the knuckle technique, and the controlled
antegrade retrograde tracking (CART) and reverse
CART techniques, as previously described (9,17).
Only drug-eluting stents were implanted.
STATISTICAL ANALYSIS. Clinical characteristics,
angiographic features, and in-hospital and follow-up
events were reported through standard descriptive
analyses for large samples assumed to follow a
normal distribution. Continuous variables are pre-
sented as mean  SD and categorical variables as
frequencies and percents. The Cochran-Armitage
trend test was used to compare success rates be-
tween years. Student t tests and chi-square tests (or
Fisher exact tests when at least 25% of values showed
expected cell frequencies <5) were used for compar-
ison regarding procedural success, except for J-CTO
score, for which the Wilcoxon test was used. We tried
to identify clinical and/or angiographic prognostic
FIGURE 2 Numbers of Procedures and Rate of Procedural Success
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2391factors of procedural failure through logistic regres-
sion analysis among age, sex, diabetes, ejection
fraction <35%, history of MI, prior coronary artery
bypass grafting (CABG), prior PCI, occlusion duration
(<12 or $12 months [the median of the likely and
certain] or undetermined), occlusion length (<20
or $20 mm), interventionalist experience (<50, 50 to
100, or >100 retrograde CTO PCIs), and J-CTO score.
Univariate analyses were performed, and multivar-
iate Cox proportional hazards regression modeling
using purposeful selected covariates was applied to
determine the independent predictors of long-term
MACCE occurrence. All univariate variables with
p values <0.10 were included in the model. Variables
judged to be of clinical importance from previous
published research were included in the multivariate
model-building process despite p values >0.10. The
univariate model included the following clinical and
angiographic variables: age, sex, diabetes, chronic
obstructive pulmonary disease, ejection fraction
<35%, prior MI, prior CABG, prior PCI, CTO vessel,
occlusion duration, number of previous attempts,
CTO length, J-CTO score $3, number of implanted
stents, and stent length. Regarding symptom
changes, McNemar’s test was used to compare angina
and dyspnea status before the index procedure and
during follow-up. Two-tailed p values <0.05 were
considered to indicate statistically signiﬁcant differ-
ences for all analyses performed. Statistical analysis
was performed using SAS version 9.1 (SAS Institute,
Cary, North Carolina).
RESULTS
BASELINE CLINICAL AND LESION CHARACTERISTICS.
During the 5-year study period at the 44 centers of
the EuroCTO Club, retrograde CTO PCI was performed
in 1,395 patients, corresponding to 1,582 lesions.
Antegrade CTO PCI was performed in 7,205 patients,
corresponding to 8,007 lesions (Figure 1). Overall,
16 centers (36.4%) contributed to the 5-year retro-
grade experience; 5 (11.4%) started retrograde CTO
interventions only in the last year of the study (2012),
while the contribution of the remaining 23 centers
(52.2%) in retrograde CTO PCI ranged from 2 to
4 years of experience.
The relative number of retrograde procedures
increased over time, reaching 25.1% of all CTOs
treated in 2012 (Figure 2). Retrograde CTO procedure
volumes of #50, >50 but <100, and >100 were
attained by 35, 5, and 4 centers, respectively, during
the study period, corresponding to 530, 303, and 562
patients enrolled. Baseline patient clinical character-
istics of the retrograde CTO cohort are shown inTable 1 and baseline lesion characteristics in Table 2
according to procedural success or failure. The mean
age was 62.0  10.4 years, and 88.5% were men. The
CTO target vessel was the right coronary artery
(70.4%), circumﬂex coronary artery (7.8%), left
anterior descending coronary artery (20.3%), and
left main artery or a bypass graft (1.5%). Prior failed
antegrade attempts (by non-CTO-dedicated oper-
ator) were documented in 42.5% of patients, and
these did not affect the procedural success rate
(p ¼ 0.97). At the time of enrollment in ERCTO, the
retrograde approach was used as a ﬁrst strategy in
76.2% of cases and after prior failed antegrade
TABLE 1 PCI Patient and Clinical Characteristics According to Procedural Success,
2008 to 2012
Overall
(n ¼ 1,395)
Procedural Success
(n ¼ 1,060 [76%])
Procedural failure
(n ¼ 335 [24%])
p
Value
Age, yrs 62.0  10.4 61.4  10.5 63.9  10.0 0.0001
Men 88.5 86.6 89.4 0.15
Current or former smokers 57.9 58.9 54.7 0.13
Clinical presentation
Asymptomatic 10.0 10.4 9.6
Stable angina 84.1 84 84.4 0.95
Unstable angina 5.7 5.5 6.0
MI 0.2 0.3 0.0
Hypertension 77.3 77.5 76.7 0.74
Hyperlipidemia 78.9 79.5 76.7 0.27
Diabetes 29.0 27.5 33.7 0.04
LVEF <35% 6.0 6.2 5.4 0.62
History of MI 43.5 44.2 41.5 0.33
History of CABG 17.6 16.9 20.0 0.14
History of stroke 2.5 1.9 4.5 0.007
Prior PCI 55.9 55.8 56.1 0.96
Coronary disease status 0.32
1-vessel disease 40.2 39.9 41.3
2-vessel disease 31.7 32.7 28.7
3-vessel disease 28.1 27.4 30.0
Values are mean  SD or %.
CABG ¼ coronary artery bypass grafting; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction;
PCI ¼ percutaneous coronary intervention.
TABLE 2 Lesion Characteristics According to Procedural Success, 2008 to 2012
Overall
(n ¼ 1,582)
Technical Success
(n ¼ 1,191 [75%])
Technical Failure
(n ¼ 391 [25%])
p
Value
CTO target vessel 0.20
RCA 70.4 69.4 73.4
LCX 7.8 3.9 6.1
LAD 20.3 20.9 18.4
LM/graft 1.5 1.3 2.0
Prior failed antegrade
attempt for CTO PCI
42.5 42.6 42.5 0.97
CTO duration determined
(months) (n ¼ 1,011
[63.9%])
46.3  63.8 44.2  62.1 52.9  68.9 0.08
J-CTO score for retrograde 3 (2–3) 3 (2–3) 3 (2–3) 0.002
Occlusion length, mm 38.4  22.5 36.3  21.6 38.4  25.0 0.01
Stump morphology 0.0005
Tapered 27.6 29.5 21.7
Blunt 55.8 55.7 56.4
Cannot be identiﬁed 16.6 14.8 21.9
Proximal tortuosity 0.0004
Straight 42.5 44.1 37.6
Slight 14.7 15.0 13.6
Moderate 28.5 28.8 27.6
Severe 9.7 8.1 14.6
Not applicable 4.6 3.9 6.6
Heavy calciﬁcation 20.2 16.6 31.0 <0.0001
Values are %, mean  SD, or median (interquartile range).
CTO ¼ chronic total occlusion; J-CTO ¼ Multicenter CTO Registry in Japan; LAD ¼ left anterior descending
coronary artery; LCX ¼ left circumﬂex coronary artery; LM ¼ left main coronary artery; PCI ¼ percutaneous
coronary intervention; RCA ¼ right coronary artery.
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2392attempts (during the same procedure) in 23.8% of
cases. J-CTO scores were statistically higher in le-
sions with procedural failures (p ¼ 0.002). The
presence of heavy calciﬁcation, found in 20.2% of
lesions, was signiﬁcantly associated with procedural
failure (p < 0.0001).
PROCEDURAL CHARACTERISTICS, COMPLICATIONS, AND
IN-HOSPITAL OUTCOMES. Table 3 shows procedural
characteristics of the retrograde cases. The retrograde
strategy as the ﬁrst approach was more successful
than after a failed antegrade approach (82.2% vs.
53.1%; p < 0.001). In successful cases, the retrograde
crossing technique was CART (13.9%), reverse CART
(16%), touching wires (22%), or simple retrograde
wire crossing (31.2%). In the remaining cases (17%),
the operator did not describe the retrograde tech-
nique used.
The retrograde route was through septal collateral
vessels in 62.7% of cases, epicardial collateral vessels
in 13.4% and bypass grafts in 3.9%. In 20.0% of cases,
information was not available. In successful cases,
drug-eluting stents were implanted, with a mean
stent length of 74.3  32.8 mm. The mean procedural
time was 156.3  63.5 min, mean ﬂuoroscopy time
66.7  36.3 min, and mean contrast volume 379.3 
185.9 ml. These values were inﬂuenced by J-CTO
score for all 3 parameters (p < 0.001 for all), as shown
in Figure 3.
Thirteen patients (0.8%) experienced in-hospital
MACCEs in the retrograde CTO cohort, compared
with 0.5% of patients in the anterograde group.
Table 4 reports complications and in-hospital out-
comes with retrograde procedures. No differences
were observed in terms of MACCEs, Q-wave MI,
non-Q-wave MIs, coronary perforation, or cardiac
tamponade according to the collateral route used
for the retrograde approach (p ¼ NS for all).
Compared with patients who underwent the anter-
ograde approach, those who underwent retrograde
PCI experienced higher rates of complications,
particularly coronary perforations and tamponade
(Online Table 1).
SUCCESS RATES. Overall, the procedural success
rate was 75.3%. This rate has increased since 2009
(73.5%, 65.8%, 73.0%, 74.7%, and 79.2% annual suc-
cess rates from 2008 to 2012, respectively). Clinical
success was achieved in 1,126 lesions (71.2%). Proce-
dural success for retrograde cases related to retro-
grade J-CTO score and operator experience is shown
in Figure 4.
Both univariate and multivariate prognostic anal-
yses (Table 5) demonstrated that low experience
and lesion complexity (measured by J-CTO score)
TABLE 3 Procedural Characteristics According to Procedural Success, 2008 to 2012
Overall
(n ¼ 1,582)
Procedural
Success
(n ¼ 1,191 [75%])
Procedural
Failure
(n ¼ 391 [25%])
p
Value
Collateral used
Septal 62.7 65.3 56.0
Epicardial 13.4 13.8 11.4
Bypass graft 3.9 4.3 2.4
Missing 20.0 16.7 30.2
Retrograde crossing technique NA
CART — 13.9 —
Reverse CART — 16.0 —
Touching wire — 22.0 —
Retrograde wire crossing — 31.2 —
Missing — 17.0 —
Retrograde as ﬁrst approach 76.2 83.2 55.0 <0.0001
Retrograde after antegrade
failed approach
23.8 16.8 45.0
Intravascular ultrasound use 9.2 10.6 NA NA
Stent diameter, mm NA 3.23  0.44 NA NA
Total stent length, mm NA 74.3  32.8 NA NA
Number of stents NA 2.85  1.25 NA NA
Drug-eluting stents only NA 85.4 NA NA
Bare-metal stents only NA 2.4 NA NA
Both types of stent NA 9.7 NA NA
Missing NA 2.5 NA NA
Balloon angioplasty only NA 2.2 NA NA
Total procedure time, min 156.3  63.5 159.1  62.9 147.9  64.8 0.003
Total ﬂuoroscopy time, min 66.7  36.3 67.5  34.9 64.3  40.0 0.16
Total contrast volume, ml 379.3  185.9 387.7  181.4 353.6  196.9 0.002
Values are % or mean  SD.
CART ¼ controlled antegrade retrograde tracking; NA ¼ not applicable.
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2393negatively affected the ﬁnal outcome (p < 0.0001).
Age (per 10-year increase) was also found to be an
independent prognostic factor at multivariate anal-
ysis (odds ratio: 1.19; 95% conﬁdence interval [CI]:
1.03 to 1.34; p ¼ 0.02).
CLINICAL FOLLOW-UP. Among the study popula-
tion, data on clinical follow-up were available in
931 patients (66.7%). These patients were more
frequently smokers and dyslipidemic and showed a
higher rate of prior PCI compared with those lost to
follow-up (Online Table 2). The mean clinical follow-
up period was 24.7  15.0 months (median 23
months). Cardiac death occurred in 18 patients (1.9%),
while all-cause mortality was 3.9%. MI and stroke
occurred in 32 (3.4%) and 6 (0.6%) patients, respec-
tively; the rate of further revascularization, either
percutaneously or surgically, was 13%. Overall,
MACCEs occurred in 127 patients (13.6%).
In comparison with patients with failed retrograde
PCI, successfully revascularized patients showed
lower rates of cardiac death (0.6% vs. 4.3%, respec-
tively; p < 0.001), MI (2.3% vs. 5.4%, respectively;
p ¼ 0.001), further revascularization (8.6% vs.
23.6%, respectively; p < 0.001), overall MACCEs
(8.7% vs. 23.9%, respectively; p < 0.001) (Figure 5),
and rehospitalization (14.2% vs. 25%, respectively;
p < 0.001).
The multivariate Cox regression analysis identiﬁed
female gender (hazard ratio [HR]: 2.06; 95% CI: 1.33 to
3.18; p ¼ 0.001), prior PCI (HR: 1.73; 95% CI: 1.16 to
2.60; p ¼ 0.011), low left ventricular ejection fraction
(HR: 2.43; 95% CI: 1.22 to 4.83; p ¼ 0.011), J-CTO
score $3 (HR: 2.08; 95% CI: 1.32 to 3.27; p ¼ 0.002),
and procedural failure (HR: 2.48; 95% CI: 1.72 to 3.57;
p < 0.001) as independent predictors of MACCEs at
long-term follow-up (Figure 6). Compared with
angina and dyspnea status before the index retro-
grade PCI, patients who underwent retrograde CTO
PCI showed a signiﬁcant reduction in symptoms
during follow-up (Figure 7).
DISCUSSION
From 2008 to 2012, highly skilled CTO-dedicated op-
erators in the ERCTO registry performed retrograde
approach procedures in 16.5% of cases. The number of
retrograde procedures increased in 2011 and 2012,
reaching 25% in the latter year, and was associated
with high procedural and clinical success (75.3% and
71.2%, respectively), low major complication rates,
and good long-term outcomes.
Although favorable outcomes of the retrograde
approach in CTO revascularization were recentlyachieved in selected centers (13–15), operators did not
unanimously embrace this technique. Indeed, suc-
cess depends on the operator’s skill and experience.
More recently, the safety and effectiveness of the
retrograde PCI approach for CTO performed by inde-
pendent operators in the real world were established
by a scientiﬁc organization called the Retrograde
Summit, which published the results of a registry
conducted by Tsuchikane et al. (16). This study was
conducted over 2-year period and included 801 pa-
tients with CTOs revascularized via the retrograde
approach (26.6% of the CTOs treated); overall proce-
dural and clinical success rates were 84.8% and
83.8%, respectively (16). They demonstrated that the
use of channel dilator–modiﬁed strategies of the
retrograde approach signiﬁcantly improved the suc-
cess rate, except in the case of severe calciﬁcations at
the CTO location.
The results of the present study show slightly
lower procedural success (75%) than obtained by the
Japanese operators (16), with a similar difference
FIGURE 3 Procedural Details According to J-CTO Score
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TABLE 4 Procedural Complications and In-Hospital Outcomes in Retrograde Lesions,
2008 to 2012
Overall
(n ¼ 1,582)
Procedural
Success
(n ¼ 1,191)
Procedural
Failure
(n ¼ 391)
p Value,
Success vs.
Failure
Procedural complications 108 (6.8) 65 (5.5) 43 (11.0) 0.0001
PE without tamponade 9 (0.6) 7 (0.6) 2 (0.5) 0.99
PE with tamponade 15 (1.0) 10 (0.8) 5 (1.3) 0.55
PE, surgical intervention 2 (0.1) 0 (0.0) 2 (0.5) NC
Collateral perforation/
hematoma
31 (2.0) 18 (1.5) 13 (3.3) 0.02
Stent thrombosis 3 (0.2) 2 (0.1) 1 (0.2) NA
Vascular complications 16 (1.0) 10 (0.8) 6 (1.5) 0.24
Collateral donor vessel
thrombus or dissection
30 (1.9) 17 (1.4) 13 (3.3) 0.02
In-hospital outcomes
Non-Q-wave MI 5 (0.3) 3 (0.3) 2 (0.5) NC
Q-wave MI 2 (0.1) 2 (0.2) 0 (0.0) NC
Emergency CABG 2 (0.1) 1 (0.08) 1 (0.2) NC
Emergency re-PCI 2 (0.1) 1 (0.08) 1 (0.2) NC
Death 2 (0.1) 0 (0.0) 2 (0.5) NC
Stroke 0 (0.0) 0 (0.0) 0 (0.0) NC
Values are n (%).
PE ¼ pericardial effusion; NC ¼ statistical data do not converge; other abbreviations as in Tables 1 and 3.
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2394(4%) between clinical and procedural success rates.
Similar results were obtained in a multicenter registry
in the United States, with procedural success of 81.4%
and clinical success of 79.4% (15). A possible expla-
nation for the lower success rate in our study
compared with the Japanese and American registries
could be ascribed to the larger numbers of patients
and operators included in the study. Furthermore,
given that the retrograde technique was used also
after failed antegrade attempts, its use is determinant
to achieve success in those cases with unfavorable
anatomy for antegrade recanalization; thus a
decreased success rate with the antegrade approach is
an expected ﬁnding.
In our patients, higher success rates were observed
when the retrograde approach was the primary
strategy adopted, compared with its use after ante-
grade failure (82.2% vs. 53.1%; p < 0.001). This is
similar to our earlier European experience for some
operators (9) and highlights how in very complex
CTOs with expected antegrade low success rate, the
retrograde approach might be preferable as the
FIGURE 4 Procedural Success According to J-CTO Score and Operator Experience
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TABLE 5 Univariate and Multivariate Logistic Regression Modeling, Procedural Failure
Univariate Multivariate
OR 95% CI p Value OR 95% CI p Value
Age, per 10-yr increase 1.24 1.11–1.39 0.0002 1.19 1.03–1.34 0.02
Men 0.72 0.51–1.02 0.07 0.70 0.47–1.05 0.08
Diabetes 1.24 0.97–1.59 0.09 1.16 0.86–1.55 0.34
Ejection fraction <35% 0.85 0.52–1.40 0.52 0.89 0.50–1.58 0.68
History of MI 0.84 0.67–1.07 0.15 0.91 0.68–1.20 0.48
History of CABG 1.21 0.91–1.63 0.19 1.22 0.81–1.64 0.44
Prior PCI 1.01 0.80–1.27 0.93 0.98 0.75–1.32 0.95
Occlusion duration
$12 vs. <12 months 1.33 0.98–1.79 0.07 1.33 0.93–1.89 0.10
Undetermined vs. <12 months 1.44 1.04–2.00 1.51 1.03–2.20
Occlusion length $20 vs. <20 mm 1.23 0.85–1.78 0.27 0.96 0.59–1.56 0.86
Experience <0.0001 <0.0001
<50 vs. >100 procedures 2.47 1.88–3.26 3.00 2.14–4.21
50–100 vs. >100 procedures 2.36 1.72–3.23 2.04 1.42–2.92
J-CTO score 0.01 0.004
Easy vs. very difﬁcult 0.47 0.16–1.38 0.56 0.10–2.91
Intermediate vs. very difﬁcult 0.74 0.48–1.14 0.56 0.33–0.95
Difﬁcult vs. very difﬁcult 0.64 0.47–0.87 0.55 0.38–0.79
CI ¼ conﬁdence interval; J-CTO ¼ Multicenter CTO Registry in Japan; OR ¼ odds ratio; other abbreviations as in
Table 1.
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2395primary strategy in experienced hands. Indeed, a ﬁrst
antegrade failure may lead to higher operator and
patient fatigue and increased contrast consumption
or radiation exposure, which might compromise the
success of the retrograde bailout strategy, the latter
being the only reliable alternative way of recanaliza-
tion in some very complex lesions, given the recent
development of dedicated devices and wires for such
a strategy.
Furthermore, the retrograde approach might be
a feasible procedure when antegrade wiring seems
to be very difﬁcult because of anatomic factors
(ostial CTO, absence of stump, CTO length >30
mm, presence of side branch or heavy calciﬁcation
at the proximal cap, and proximal vessel tortuos-
ity), in the presence of visible and continuous
collateral vessels, healthy donor vessels, and in
repeat attempt procedures after previous failures
(21,22).
Among the different techniques used, the CART
and reverse CART techniques were used in almost
30% of cases, as well as retrograde wire crossing
(30%). The kissing wire technique was used in 22%
of cases. In the remaining 17% of cases, data were
missing. We had no strict rules for the selection of
a particular technique, and sometimes a combina-
tion of techniques was necessary to achieve suc-
cess. However, reverse CART has recently become
the technique of choice by the use of a channel
dilator, as pointed out in other reports (12,16). In
contrast, placing an antegrade wire may be wise
and in many cases helpful to target the proximal
CTO cap.
In this study, we found that procedural success
decreased with patient age, presence of diabetes, and
history of previous stroke, probably because of un-
derlying severe and diffuse atherosclerosis in these
patients. Furthermore, age (per 10-year increase) was
an independent predictor of procedural failure by
multivariate analysis. In these older patients, opera-
tors might be more reluctant to perform more
cumbersome procedures. In a different setting (acute
coronary syndrome), Jolly et al. (23) demonstrated
that procedural volume and expertise are important
for PCI success and outcome, particularly for the
radial approach. Thompson et al. (14) showed that in
the United States, CTO experience measured by CTO-
coronary PCI volume is associated with improved
technical success rates, without compromising pa-
tient safety. Similarly, in this study, we showed that
operators’ experience was highly related to proce-
dural success in the setting of retrograde procedures.
Importantly, procedural success was associated with
better outcomes.THE J-CTO SCORE AS A DIFFICULTY-GRADING AND
ASSESSMENT TOOL. The prediction rule based on
the J-CTO score was recently found to be closely
associated with successful antegrade recanalization
(20). We proposed the J-CTO score as an objective tool
for predicting the difﬁculty level also for the retro-
grade approach and found that this score was useful
for assigning procedural success in relation to
FIGURE 5 Clinical Outcome According to Procedural Success
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FIGURE 6 Predictors of Long-Term Clinical Outcomes
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adverse cardiac and cerebrovascular events at long-term follow-up.
COPD ¼ chronic obstructive pulmonary disease.
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2396operators’ levels of skill for the objectively deter-
mined difﬁculty of dealing with these lesions. Indeed,
procedural success in minimally and moderately
experienced retrograde operators decreased with
increased J-CTO score, in contrast to experienced op-
erators. Furthermore, age (per 10-year increase) and
increased J-CTO score were signiﬁcantly associated
with increased procedural failure, conﬁrming that
prediction of success should take into account these
latter predictors. Interestingly, even longer proce-
dural and ﬂuoroscopy times were signiﬁcantly related
to increased J-CTO score, apart from contrast load.
OUTCOME AFTER RETROGRADE RECANALIZATION.
There are several studies suggesting that successful
CTO PCIs are associated with better outcomes than
failed CTO revascularization procedures (24–27).
Niccoli et al. (28) showed in a cohort of 317 consecu-
tive patients that successful CTO revascularization
can reduce the rate of 3-year cardiac events in com-
parison with unsuccessful procedures (9% vs. 26%,
respectively; p ¼ 0.008); moreover, the investigators
reported a worse prognosis in patients affected with
multivessel disease.
Recently, Jones et al. (29) reported in a single-
center experience the long-term survival of patients
with stable angina who underwent CTO PCI attempts,
showing a reduction of mortality of patients with
successful CTO revascularization, in comparison with
patients with unsuccessful CTO PCI (4.5% vs. 17.2%,
respectively; p < 0.0001). Several reasons may
explain this fact, including the complications related
to CTO failure, which can lead to major adverse
events. Moreover, PCI failure can be a marker of dis-
ease burden and other comorbidities that might limit
the vigor of CTO attempts.
A recent meta-analysis by Joyal et al. (25)
addressed the outcomes of patients who underwent
successful versus unsuccessful CTO interventions.
Although no randomized trial was included, the in-
vestigators analyzed 13 observational studies
comparing PCI with planned medical therapy. This
analysis demonstrated a survival beneﬁt for those
who underwent CTO recanalization (14.3% vs. 17.5%;
odds ratio: 0.56) and reductions in the need for sub-
sequent CABG and in residual or recurrent angina.
Mehran et al. (24) reported long-term outcomes in
a prospective multicenter registry, showing that
successful PCI was an independent predictor of lower
cardiac mortality and a reduced need for CABG.
Similar results were shown by a large recent analysis
of the UK Central Cardiac Audit Database, in which
successful CTO PCI was associated with improved
long-term survival (30).
FIGURE 7 Changes in Angina and Dyspnea Status After Retrograde CTO PCI
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2397We report the short- and long-term outcomes of
retrograde CTO revascularization in a large cohort of
patients, showing the safety of the retrograde
approach and the good prognostic impact of attaining
angiographic success in the setting of a complex CTO
procedure. Considering the complexity of attempted
lesions, MACCE and further revascularization rates
(13.6% and 13%, respectively) were satisfactory and
comparable with previous outcomes by the ante-
grade approach (11,26,31). Very recently, Michael
et al. (32) reported the only other retrograde 2-year
clinical follow-up in a small group of 41 patients,
showing that although the retrograde approach was
safe, it was associated with a high rate of further
revascularization (45%), likely due to longer stent
lengths, more complex lesions, and greater use of
dissection and re-entry techniques compared with
antegrade procedures. The higher rates of need for
further revascularization might be explained by the
limited number of patients and a success rate as
low as 65.8% (32). Indeed, in our cohort, this rate
was higher in the unsuccessful retrograde PCI group
(23.6% vs. 8.6%; p < 0.001).
In accordance with previous studies, we found that
independent predictors of MACCEs were procedural
failure (24,28,33) and female sex (34). As expected,
low ventricular ejection fraction and prior PCI were
also associated with MACCE, and for the ﬁrst time, we
showed that J-CTO score was a predictor of an unfa-
vorable long-term outcome. This might be related to
the higher atherosclerotic burden and lesion
complexity of patients with higher J-CTO score,
requiring longer stent segment implantation.
STUDY LIMITATIONS. As in other retrograde CTO
registries, this study was limited by its observational
design, in which unmeasured variables and selection
bias on the part of operators toward cases may have
inﬂuenced the results. Indeed, patients were treated
by highly skilled, experienced operators; therefore,
the results may not be generalized to less experienced
operators in the real world. In addition, procedures
were performed over a period when changes in
operator experience and techniques occurred at
different institutions. Clinical follow-up was missing
in approximately one-third of the initial cohort,
and the follow-up period was not homogeneous
between patients (Online Figure 1). However, this
registry represents the largest study reporting long-
term follow-up after retrograde CTO PCI, with a
median follow-up period of 23 months. To control
the quality and reliability of outcome results pre-
sented, we included only centers able to provide
satisfactory rates of follow-up data. Of note, pa-
tients with more comorbidities or prior PCI were
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Increased success rate, good long-term outcomes, and reduction in symptoms. CTO ¼ chronic total obstruction; PCI ¼ percutaneous coronary intervention.
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2398more likely to be adherent to follow-up. Data
regarding collateral route and crossing technique
were missing in some cases. Finally, angiographic
dependent and clinical outcomes were not inde-
pendently adjudicated.
CONCLUSIONS
Our study shows that among dedicated European
operators, retrograde CTO PCI is performed exten-
sively and is associated with favorably high success
and low complication rates. Moreover, successfulretrograde CTO PCI was associated with favorable
long-term clinical outcomes and symptom alleviation
(Central Illustration).
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: A
retrograde approach to myocardial revascularization
in patients with CTOs, when performed by experienced
operators, can enhance the success of PCI.
TRANSLATIONAL OUTLOOK: More work is required
to develop better criteria for the selection of patients for
retrograde recanalization of coronary arteries with CTOs,
on the basis of lesion characteristics.
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